Oxybutynin-induced heatstroke in an elderly patient

Annals of Pharmacotherapy

Volumn 30, Issue 2, 1996, Pages 144-147

  Adubofour, Kwabena O ^a   Kajiwara, Grace T ^b   Goldberg, Charles M ^a   King Angell, Joan L ^a  

^a KAISER PERMANENTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; DANTROLENE; DIGOXIN; DIURETIC AGENT; GLUTETHIMIDE; INHALATION ANESTHETIC AGENT; METOPROLOL; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OXYBUTYNIN; PHENCYCLIDINE; PHENOTHIAZINE DERIVATIVE; SALICYLIC ACID DERIVATIVE; SODIUM CHLORIDE;

AGED; ARTICLE; CASE REPORT; CEREBROVASCULAR ACCIDENT; CONFUSION; DOSE RESPONSE; DRUG FEVER; HEAT STROKE; HUMAN; HYPERTHERMIA; MALE; MALIGNANT HYPERTHERMIA; NEUROLEPTIC MALIGNANT SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SICK SINUS SYNDROME;

EID: 0030021237     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000207     Document Type: Article

References (21)

1. Heat-related deaths. Philadelphia and United States. MMWR Morb Mortal Wkly Rep 1994;43:453-5.
2. Clowes GH Jr, O'Donnell TF Jr. Heatstroke. N Engl J Med 1974;291:564-7.
3. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993;77:185-202.
4. Shibolet S, Lancaster MC, Danon Y. Heatstroke. A review. Aviat Space Environ Med 1976;47:280-301.
5. Simon HB. Hyperthermia. N Engl J Med 1993;329:483-7.
6. Delaney KA. Heatstroke. Underlying processes and lifesaving management. Postgrad Med 1992;91:379-88.
7. Knochel JP, Caskey JH. The mechanism of hypophosphatemia in acute heatstroke. JAMA 1977;238:250-4.
8. Sprung CL, Portocarrero CJ, Fername AV, Weinburg PF. The metabolic and respiratory alterations of heatstroke. Arch Intern Med 1980;140:665-9
9. Gader AM, Al-Mashhadani SA, Al-Harthy SS. Direct activation of platelets by heat is the possible trigger of the coagulopathy of heatstroke. Br J Haematol 1990;74:86-92.
10. Keatinge WR, Coleshaw SRK, Easton JC, Cotter F, Mattock MB, Chelliah R. Increased platelet and red cell counts, blood viscosity, and plasma cholesterol levels during heat stress, and mortality from coronary and cerebral thrombosis. Am J Med 1986;81:795-800.
11. Bouchama A, Al-Sedairy S, Siddiqui S, Shail E, Reseig M. Elevated pyrogenic cytokines in heatstroke. Chest 1993;104:1498-502.
12. Delay J, Deniker P. Drug-induced extrapyramidal syndromes. In: Bruyn GW, ed. Handbook of neurology. Diseases of the basal ganglia. Vol 6. Amsterdam: North Holland Publishing, 1968:248-66.
13. Friedman JH, Feinberg SS, Feldman RG. A neuroleptic malignant-like syndrome due to levodopa therapy withdrawal. JAMA 1985;254:2792-5.
14. Keyser DL, Rodnitzky RL Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy. Arch Intern Med 1991;151:794-6.
15. Rosebush PI, Stewart TD, Gelenberg AJ Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry 1989;50:295-8.
16. Nimmo SM, Kennedy BW, Tullett WM, Blyth AS, Dougall JR. Drug-induced hyperthermia. Anaesthesia 1993;48:892-5.
17. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-45.
18. Johnson C, Edleman KJ. Malignant hypenhermia. A review J Perinatol 1992;12:61-71.
19. Kaus SJ, Rockoff MA. Malignant hyperthermia. Pediatr Clin North Am 1994;41:221-37
20. Condrescu M, Lopez JR, Medina P, Alamo L. Deficient function of the sarcoplasmic reticulum in patients susceptible to malignant hyperthermia. Muscle Nerve 1987;10:238-41.
21. Kolb ME, Norne ML, Martz R. Dantrolene in human malignant hyperthermia. Anesthesiology 1982;56:254-62.